Gender-questioning children will have to be at least 11 years old to take part in a clinical trial of puberty-blocking drugs.
Minimum age of 11 set for UK puberty blocker trial
Related Posts
US to end funding of South Africa’s HIV programmes over claims of Afrikaner persecution
The US says South Africa is not doing enough to protect the white-minority Afrikaner community.